This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1931 and headquartered in Northbrook, Illinois, The Allstate Corporation is the third-largest property-casualty (P&C) insurer and the largest publicly-held personal lines carrier in the U.S. The company also provides a range of life insurance and investment products to its diverse customer base. It provides insurance products to approximately 16 million households through more than 12,000 exclusive agencies and financial specialists in the U.S. and Canada.
Allstate (ALL) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
The latest trading day saw Allstate (ALL) settling at $202, representing a +1.89% change from its previous close.
Why Is Allstate (ALL) Up 2.9% Since Last Earnings Report?
by Zacks Equity Research
Allstate (ALL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Chubb Lags Industry, Trades at a Premium: How to Play the Stock
by Tanuka De
Investors who already hold CB stock should retain it, as this insurance behemoth is unlikely to disappoint. New investors can wait for a better entry point.
Investors Heavily Search The Allstate Corporation (ALL): Here is What You Need to Know
by Zacks Equity Research
Allstate (ALL) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
BRK.B Stock Expensive: Should You Buy It Post Solid Q4 Show?
by Tanuka De
Investors who already own Berkshire shares should hold it, while others can wait for some more time before investing.
AMERISAFE's Q4 Earnings Beat on Higher Premiums Earned
by Zacks Equity Research
AMSF hikes quarterly cash dividend to 39 cents per share from 37 cents.
Allstate Sweetens the Deal With a Dividend Hike: Should You Bite?
by Kaibalya Pravo Dey
ALL has raised its dividend five times over the past five years, highlighting its commitment to shareholder returns.
Progressive's January Earnings Rise: Time to Buy the Stock?
by Tanuka De
PGR seems well-poised on improving premiums, steady policy life expectancy, investment in technology and a solid capital position.
Will Lower Premiums Earned Affect ProAssurance's Q4 Earnings?
by Zacks Equity Research
PRA's fourth-quarter results are likely to have benefited from growing investment income and lower costs.
Top Research Reports for Meta Platforms, BlackRock & Palo Alto
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), BlackRock, Inc. (BLK) and Palo Alto Networks, Inc. (PANW), as well as two micro-cap stocks, Seneca Foods Corporation (SENEA) and Crown Crafts, Inc. (CRWS).
TRV Stock Lags Industry, Trades at a Premium: Will You Still Buy It?
by Tanuka De
Travelers is set to gain from continued strong renewal rate change and retention and increase in new business.
Roku and Constellation Brands have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Roku and Constellation Brands have been highlighted as Zacks Bull and Bear of the Day.
Berkshire Hathaway Pre-Q4 Earnings Analysis: Time to Sell the Stock?
by Tanuka De
BRK.B is expected to witness a decline in its top line but an improvement in bottom line when it reports fourth-quarter 2024 results.
TRV Rises 9.5% in a Year but Lags Industry: How to Play the Stock
by Zacks Equity Research
Travelers gains from strong renewal rate change, retention and an increase in new business supported by a compelling portfolio and solid capital position.
Zacks Industry Outlook The Progressive, Chubb, The Travelers, The Allstate and Arch Capital
by Zacks Equity Research
The Progressive, Chubb, The Travelers, The Allstate and Arch Capital have been highlighted in this Industry Outlook article.
5 P&C Insurers to Watch Amid Soft Pricing, Low Interest Rate
by Tanuka De
Zacks Property and Casualty Insurance players like PGR, CB, TRV, ALL and ACGL are likely to benefit from catastrophes that drive policy renewal rate and pricing.
Allstate Q4 Earnings Beat on Strong Premium & Investment Income
by Zacks Equity Research
ALL agrees to divest the Group health business to Nationwide for $1.25 billion in cash.
Allstate (ALL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Allstate (ALL) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Allstate (ALL) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Allstate (ALL) delivered earnings and revenue surprises of 17.82% and 0.01%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for These Three Insurance Stocks in Q4 Earnings?
by Debasmita Chatterjee
Insurers like ALL, MET and AFL are likely to have witnessed premium growth in Q4. Lower interest rates are expected to have pressured life insurers' returns, while M&A, tech investments and catastrophe impacts shaped industry trends.
ALL to Sell Group Health Unit, Intensifies Focus on Core Operations
by Zacks Equity Research
Allstate is set to divest its Group Health business to Nationwide for $1.25 billon. This divesture is likely to boost deployable capital by $0.9 billion while adversely impacting the insurer's ROE by 75 bps.
Principal Financial to Report Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
PFG's Q4 results are likely to reflect a rise in fee revenues, higher yields, favorable market performance and higher sales of single premium group annuities.
Intercontinental to Report Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
ICE's fourth-quarter results are likely to reflect strong trends across fixed-income data and analytics and growth in other data and network services businesses.
Analysts Estimate Arch Capital Group (ACGL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Arch Capital (ACGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Progressive Stock Still Worth Buying Post Q4 Earnings?
by Tanuka De
PGR seems well-poised on improving premiums, steady policy life expectancy, investment in technology and a solid capital position.